Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366
Zanders,M.M.J. ; Renehan,A.G. ; Bowker,S.L. ; Carstensen,B. ; van de Poll-Franse,L. ; Johnson,J.A.
Zanders,M.M.J.
Renehan,A.G.
Bowker,S.L.
Carstensen,B.
van de Poll-Franse,L.
Johnson,J.A.
Abstract
Description
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Keywords
SDG 3 - Good Health and Well-being
Citation
Zanders, M M J, Renehan, A G, Bowker, S L, Carstensen, B, van de Poll-Franse, L & Johnson, J A 2014, 'Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366', Diabetes Care: The Journal of Clinical and Applied Research and Education, vol. 37, no. 10, pp. e221-e222. https://doi.org/10.2337/dc14-1380
License
info:eu-repo/semantics/closedAccess
